UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CAI
676
Caris Life Sciences
CAI
$6.43B
| $33.8M | 0.01% |
1,116,191
+316,078
| +40% | +$10.1M |
|
677
BWX Technologies
BWXT
$15.6B
| $33.7M | 0.01% |
182,925
-126,818
| -41% | -$20.4M |
|
678
Norwegian Cruise Line
NCLH
$8.84B
| $33.6M | 0.01% |
1,365,556
-687,022
| -33% | -$16.7M |
|
679
Canadian Pacific Kansas City
CP
$80.5B
| $33.6M | 0.01% |
450,486
-1,742,298
| -79% | -$133M |
|
680
Cirrus Logic
CRUS
$6.26B
| $33.3M | 0.01% |
265,886
-85,071
| -24% | -$9.47M |
|
681
Trex
TREX
$5.01B
| $33M | 0.01% |
638,067
-136,021
| -18% | -$8.28M |
|
|
SNDK
682
Sandisk
SNDK
$177B
| $32.9M | 0.01% |
293,641
-203,492
| -41% | -$11.9M |
|
|
WCC
683
WESCO International
WCC
$17.7B
| $32.7M | 0.01% |
154,711
-76,796
| -33% | -$16.1M |
|
684
Charles River Laboratories
CRL
$12.8B
| $32.6M | 0.01% |
208,260
-75,467
| -27% | -$12M |
|
|
COOP
685
DELISTED
Mr. Cooper
COOP
| $32.5M | 0.01% |
154,024
-61,088
| -28% | -$11.2M |
|
686
LKQ Corp
LKQ
$6.29B
| $32.4M | 0.01% |
1,059,473
-1,827,749
| -63% | -$60M |
|
687
Roivant Sciences
ROIV
$26.2B
| $32.1M | 0.01% |
2,123,617
-651,732
| -23% | -$8.07M |
|
688
Evercore
EVR
$11.8B
| $31.8M | 0.01% |
94,309
-48,222
| -34% | -$15.1M |
|
689
Twist Bioscience
TWST
$7.25B
| $31.6M | 0.01% |
1,123,697
-95,691
| -8% | -$2.9M |
|
690
Core & Main
CNM
$8.71B
| $31.6M | 0.01% |
587,252
-309,360
| -35% | -$18.7M |
|
691
BorgWarner
BWA
$13.9B
| $31.5M | 0.01% |
717,064
-348,122
| -33% | -$13.9M |
|
692
CG Oncology
CGON
$6.66B
| $31.4M | 0.01% |
780,302
-76,295
| -9% | -$2.22M |
|
693
Macerich
MAC
$6.92B
| $31.4M | 0.01% |
1,724,727
+1,402,627
| +435% | +$24.3M |
|
694
New York Times
NYT
$10.2B
| $31.2M | 0.01% |
544,007
-274,307
| -34% | -$15.6M |
|
695
Donaldson
DCI
$11.4B
| $31.2M | 0.01% |
380,629
-201,815
| -35% | -$15.2M |
|
696
Exelixis
EXEL
$13.4B
| $31M | 0.01% |
751,613
-384,422
| -34% | -$15.5M |
|
697
Lincoln Electric
LECO
$15.4B
| $31M | 0.01% |
131,565
-63,227
| -32% | -$14.8M |
|
698
Bio-Techne
TECH
$11.3B
| $30.9M | 0.01% |
555,932
-262,206
| -32% | -$14M |
|
699
Elanco Animal Health
ELAN
$11.1B
| $30.9M | 0.01% |
1,535,271
-796,567
| -34% | -$13.3M |
|
700
Viatris
VTRS
$18.9B
| $30.9M | 0.01% |
3,120,471
-1,938,679
| -38% | -$18.9M |
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.